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Colorectal cancer (CRC) is the third most common malignant neoplasm worldwide and is
expected to affect six percent of Americans within their lifetime (National Cancer Institute,
2003). Clinicians worldwide struggle with selecting the most accurate, cost-effective CRC
screening tool. Could a noninvasive screening tool be the answer or part of the answer to the
dilemmas surrounding CRC screening?
The purpose of this correlational, replication study was to determine whether symptoms
such as rectal bleeding, change in bowel habit, and weight loss are associated with symptomatic
colorectal cancer using a sample of individuals scheduled for a routine colonoscopy. This study
can be considered a pilot study since it has never been replicated in the United States (U.S).
Data obtained from 47 Bowel Symptom Assessment Questionnaires (BSAQs) given to
patients undergoing routine colonoscopy at Greenview Regional Hospital in Bowling Green,
Kentucky were analyzed to address the research objectives of the study. None of the patients
had colorectal cancer, but 15 of the 47 patients had polyps. None of the symptoms showed a
significant correlation with polyps according to chi-square analysis. T-tests of the means of the
polyp group versus the no polyp group showed no difference between the population means for
each of the examined variables. Selva scores generated from the BSAQ did not show a
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significant relationship with the presence or absence of polyps. Additional findings, limitations,
and implications for future research are discussed.

9
CHAPTER 1
Introduction
Background and Significance
Colorectal cancer (CRC) is the third most common malignant neoplasm worldwide and is
expected to affect six percent of Americans within their lifetime (National Cancer Institute,
2003). Some individuals are at a higher risk of developing CRC. Known CRC risk factors
include: a genetic condition such as familial adenomatous polyposis or hereditary nonpolyposis
colorectal cancer, a personal history of colorectal cancer or adenomas, first degree relative with
colorectal cancer, first degree relative with adenomas diagnosed before age 60, a personal history
of breast, endometrial, or ovarian cancer, or a personal history of chronic ulcerative colitis or
Crohn’s colitis (National Cancer Institute). Interestingly, these high risk individuals account for
only 25 percent of all colorectal cancers. Thus, screening low-risk individuals is necessary to
identify the remaining 75 percent of CRC cases (National Cancer Institute).
Screening for colorectal cancer involves looking for the disease before it has symptoms
(American Cancer Society, 2003). The importance of CRC screening is evident when analyzing
the survival rates of this disease. Bennett (2002) states that the five-year survival rate for
patients diagnosed with CRC in its earliest stages is about 90%. If the disease has spread to
adjacent organs or lymph nodes, the five-year survival rate drops to 50%. Once the disease has
metastasized to distant sites, this rate drops to only 5% (Bennett). The average patient dying of
colorectal cancer will lose 13 years of life (U.S. Preventative Services Task Force, 2002).
Estimates suggest that implementation of currently available cancer prevention and screening
strategies at the population level could reduce cancer morality in the United States by
approximately 60% (Emmons, 2001).
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Research Problem
Screening for CRC can detect colorectal malignancy in its earliest stages, thus offering
patients a better prognosis after diagnosis. Unfortunately, most CRC screening methods are
invasive and expensive. While some research suggests colonoscopy to be the epitome of CRC
screening (Swaroop & Larson, 2002), there are risks involved with this procedure. Barium
enema studies and flexible sigmoidoscopies are also invasive and may be inconclusive (Swaroop
& Larson). Fecal occult blood testing, stool DNA analysis, and stool minichromosome protein
analysis are non-invasive yet require further testing if results are positive (Swaroop & Larson).
In fact, clinicians worldwide struggle with selecting the most accurate, cost-effective CRC
screening tool. Researchers in England (Selvachandran, Hodder, Ballal, Jones, and Cade, 2002)
decided to test a new CRC screening tool after studying the histories and clinical presentations of
patients with symptomatic CRC. These researchers designed a questionnaire based upon
common clinical symptoms found among CRC patients. After comparing the questionnaire
score for CRC risk with the malignancy score assigned by a senior colorectal surgeon, the
questionnaire was predictive of CRC (Selvachandran et al). Could this noninvasive screening
tool be the answer or part of the answer to the dilemmas surrounding CRC screening?
Purpose Statement
The purpose of this correlational, replication study was to determine whether symptoms
such as rectal bleeding, change in bowel habit, and weight loss were associated with
symptomatic colorectal cancer using a sample of individuals scheduled for a routine
colonoscopy. This study can be considered a pilot study since it had never been replicated in the
United States (U.S).
Development of the Framework
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The Need for Screening
Screening is included in the ideals of health promotion. Nola Pender’s Health Promotion
Model (Pender, 2001) has been used to guide research involving the screening aspects of health
promotion. Pender’s model (see Appendix A) has been used in areas such as adoloscent health
promotion (Montgomery, 2002), construction workers’ use of hearing protection (Lusk et al.,
1999), and health promotion behaviors in cardiac rehabilitation patients (Sakraida, 2002).
According to the World Health Organization (2003), any cancer screening is justified if
four criteria are met:
1) The disease is common and associated with serious morbidity or mortality.
2) Screening tests are accurate in detecting early stage disease.
3) Treatment after the detection of the disease via screening can improve prognosis when
compared to prognosis if treatment is received after usual diagnosis.
4) Studies show that the potential benefits outweigh the potential harms and costs of
screening.
Colorectal cancer meets all four criteria and is thus justified for screening. In fact, if all adults
age 50 and older had routine colorectal cancer screening, more than one third of CRC deaths
could be avoided (Centers for Disease Control, 2002).
Screening has also been shown to reduce CRC-related morbidity and mortality (Stoffel &
Syngal, 2002). Colorectal cancer screening has also been shown to be as cost-effective as
screening mammography (Winawer & Zauber, 2000). The U.S. Preventative Services Task
Force (2002) indicates that CRC screening is likely to be cost-effective regardless of the strategy
chosen; this means it will cost less than $30,000 per additional year of life gained.
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Individuals with known risk factors for CRC account for only 25 percent of all colorectal
cancers (National Cancer Institute, 2003). Thus, screening low-risk individuals is necessary to
identify the remaining 75 percent of CRC cases. The good news for those individuals with no
known risk factors is that CRC has a detectable, curable preclinical stage (adenoma) of about 8
to 12 years before it advances and becomes more fatal (Huether, 2002). Thus, CRC is ideal for
screening and early detection.
Studies show that there is room for improvement in current CRC screening campaigns.
Despite an increase in public awareness of colorectal cancer and Medicare reimbursement for
screening, colorectal cancer screening rates remain low (Barclay, 2003). In 1999, only 25.638.6% of Kentucky adults over the age of 50 had a CRC screening test within the recommended
time interval (Centers for Disease Control, 2002). Bliss and Sawchuk (2000) note that
participation in early cancer screening is effective in decreasing mortality, but fear of diagnosis
may exist as a barrier.
Almost 50% of Americans who should be screened for colorectal cancer are not doing so
at the recommended intervals (American Cancer Society, 2003). A survey of nearly 88,000
people aged 50 or older identified the screening tools being used in the U.S. (American Cancer
Society). Approximately 45% of respondents stated they had used a home fecal occult blood test
and 47% reported having sigmoidoscopy or colonoscopy at least once (American Cancer
Society). These figures do not reflect the American Cancer Society recommendations that every
adult over age 50 should have a fecal occult blood test every year and a sigmoidoscopy every
five years. A colonoscopy every 10 years is an alternative to the sigmoidoscopy every five years
(American Cancer Society).
The Family Nurse Practitioner’s Role in Screening
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Nurses have been successful in developing, implementing, and evaluating screening tools
in various areas of healthcare. For example, Janssen, Holt, and Sugg (2002) developed and
implemented a protocol for domestic violence assessment in an obstetrical setting. Their efforts
resulted in a screening rate increase of 18%, from 42% to 60%, which has been sustained for the
first 18 months of the program. Marshall, McConkey, and Moore (2003) organized obesity
health screenings for individuals with intellectual disabilities and found that a sedentary lifestyle
seemed to be the most consistent risk factor for obesity in the intellectually disabled.
Loftus and Weston (2001) reviewed the role of the nurse practitioner in nurse-led cancer
care clinics. The nurse practitioner’s skills and knowledge were evident in the care of colorectal
cancer patients (Loftus and Weston). Miller (1999) also examined the role of the nurse
practitioner (NP) in the correctional health setting. Theory-based health promotion
interventions were discussed for this setting in an effort to improve correctional facility NP
practice (Miller).
As previously stated, CRC will likely affect six percent of Americans in their lifetime
(National Cancer Institute, 2003). Since family nurse practitioners are sometimes the only
primary health care provider for patients, nurse practitioners may diagnose dozens of patients
with CRC in their careers. Rakowski, DeDecker, and Westendorp (2001) estimate that 70-90%
of colon cancers could be indemnified and removed through CRC screening before they become
invasive. Emmons (2000) adds that a substantial number of clinical trials have shown that brief
counseling by a primary care provider is effective in changing the health behaviors of many
patients.
Because health promotion is one of the cornerstones of nursing practice, screening for
malignancies is an essential responsibility of the nurse practitioner. While some specialized
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nurse practitioners are able to perform flexible sigmoidoscopy (Rakowski et al ., 2001), others
must be able to recognize the symptoms of CRC and expedite gastroenterology referral when
indicated. If nurse practitioners know which questions to ask patients in order to predict the
malignancy risk for that patient, gastroenterologists may view certain cases as more urgent than
others. This may eventually lead to earlier referral, earlier diagnosis, and earlier treatment.
Rakowski et al. (2001) measure successful nursing care by how well informed clients are
and how well prepared they are to make decisions that will keep them in a state of health.
Emmons (2000) notes that strong relationships exist beween health behaviors and risk for
leading causes of adult morbidity and mortality. Thus, informing the public about these risk
factors in the guise of health promotion may in turn reduce adult mobidity and mortality. Based
on CRC screening rates, nurses have not been providing adequate care to their clients in terms of
patient education (Rakowski et al .).
As nurse practitioners pioneer the non-invasive approach to CRC screening, patients and
community members may begin to recognize the early warning signs of CRC. This increased
awareness and knowledge of risk factors could lead to earlier reporting of symptoms to primary
care providers as well as lifestyle modifications. Nurse practitioners could also encourage other
members of the medical community to follow CRC screening guidelines and to stress the
importance of colorectal health to their patients (Rakowski et al ., 2001) .

Research Objectives
The objectives of this study were to:
1. identify variables associated with colorectal cancer using a questionnaire
administered to patients with distal colonic symptoms
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2. determine a patient’s malignancy risk score (Selva score) using the data obtained
in the questionnaire
3. evaluate the relationship between the Selva score and the presence or absence of
colorectal cancer based on pathology results from a colonoscopy.
Hypotheses
The research hypothesis for this study was that the questionnaire will show a significant
level of predictiveness for symptomatic colorectal cancer (based on the results of the point
biseral correlation coefficient). The null hypothesis for this study was that there will be no
relationship between the Selva score generated by the BSAQ and the incidence of colorectal
cancer in patients scheduled for a routine colonoscopy (also based on the results of the point
biseral correlation coefficient).
Definitions of major variables or concepts
Appraisal Tools
Questionnaire score. Data from the questionnaires was entered into the computer
database where each factor was given a numerical score. The score weights were higher with
high-risk symptoms such as rectal bleeding or more frequent, loose stools. The computer
program (MAABS) automatically generated the malignancy score (Selva score) from the values
entered for each symptom (Selvachandran et al ., 2002).
Bowel symptoms. The specific symptoms included on the patient consultation
questionnaire (see Appendix B) were: age and sex, blood per rectum (several factors), change in
bowel habits (several factors), urgency, and incomplete emptying, perianal symptoms,
abdominal symptoms, weight loss, loss of appetite, tiredness, family history, and relevant
medical history (Selvachandran et al ., 2002). The Statistical Package for the Social Sciences
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(SPSS) software was used to analyze the nominal data, such as abdominal pain, change in bowel
habit, and rectal bleeding.
Colorectal cancer classification. Colorectal cancers were classified as the absence or
presence of cancer. Adenocarcinoma, scirrhous tumors, or neuroendocrine tumors (National
Cancer Institute, n.d.) on the pathology report met the criteria for the presence of cancer.
Assumptions
There were many assumptions associated with this research proposal.
1. Primary care providers want early CRC detection for their patients.
2. Patients want early detection of CRC.
3. Patients with altered health status will seek health care.
4. Advanced practice nurses are responsible for recognizing an altered state of health.
5. Patients are open to education.
Nola Pender’s Health Promotion Model also has several assumptions that can be linked to
this research (Pender, Murdaugh, & Parsons, 2002):
1. Persons seek to create conditions of living through which they can express their unique
health potential.
2. Health professionals consitute a part of the interpersonal environment, which exerts
influence on persons throughout their lifespan.
3. Prior behavior and inherited and acquired characteristics influence beliefs, affect, and
enactment of health-promoting behavior.
4. Persons commit to engaging in behaviors from which they anticipate deriving personally
valued benefits.
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5. Persons are more likely to commit to and engage in health-promoting behaviors when
significant others model the behavior, expect the behavior to occur, and provide assistance
and support to enable the behavior.
Relevance to FNP practice
Family nurse practitioners are often the only primary health care provider for patients.
As previously stated, CRC will likely affect six percent of Americans (National Cancer Institute,
2003). This translates into dozens of patients that a nurse practitioner may treat in his or her
career. Because health promotion is one of the cornerstones of nursing practice, screening for
malignancies is essential to the nurse practitioner. The nurse practitioner must be able to
recognize the symptoms of CRC and expedite gastroenterology referral when indicated. If nurse
practitioners knew which questions to ask patients in order to predict the malignancy risk for that
patient, gastroenterologists may view certain cases as more urgent than others. This may
eventually lead to earlier referral, earlier diagnosis, and earlier treatment.
Saunders (2002) challenges nurse practitioners (NPs) to offer patient education to all
patients who are candidates for CRC screening. She encourages NPs to inform patients of the
risks, benefits, and supporting evidence for each of the 4 CRC screening techniques and then
allow the patient to make an informed choice as to which method they prefer. Saunders believes
that screening rates are low simply because patients are not aware of their options. She also
urges NPs to convince insurers to pay for colonoscopy citing the following reasons:
effectiveness, patient adherence, and it only needs to be performed every 10 years.
As nurse practitioners pioneer the non-invasive approach to CRC screening, patients and
community members may begin to recognize the early warning signs of CRC. This increased
awareness and knowledge of risk factors could lead to earlier reporting of symptoms to primary
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care providers as well as lifestyle modifications. Nurse practitioners could also encourage other
members of the medical community to follow CRC screening guidelines and to stress the
importance of colorectal health to their patients.
Significance
The future of CRC screening is in the hands of the primary care community. The
cornerstones of nursing practice include health promotion, health education, and disease
prevention. By using research-based methods to screen for CRC, perhaps mortality from the
disease can be reduced. Increased awareness in the nursing community may be all that is
necessary to begin a new trend in the early detection and more widespread screening and
prevention of colorectal cancer in this country. The BSAQ tool may offer a valuable supplement
to current protocols for colorectal cancer.
Screening can only reach its fullest potential when there is adherence by health care
providers to the proven regimens (Rakowski, DeDecker, & Westendorp, 2001). Other ways to
reduce mortality and morbidity involve timely and appropriate diagnostic evaluation of any
screening abnormalities. Primary care providers must educate all adult clients about CRC
prevention and screening and must also follow-up on any positive screening results.
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CHAPTER 2
Literature Review
Colorectal cancer is the second leading cause of cancer deaths in the United States and
the third most common cancer in the U.S. If colon cancer is found in its early stages, it is often
curable. Studies show that approximately 50% of all deaths from colorectal cancer can be
prevented through lifestyle modification and implementation of widespread screening (Winawer
& Zauber, 2000). With the wide variety of CRC screening tools, intense debate over the
efficacy, cost-effectiveness, and patient compliance has led to vast amounts of research.
Relevant Theoretical Literature
Nola Pender’s Health Promotion Model (HPM) is relevant to this research (see Appendix
A). Pender believes that prior related behavior, personal factors, perceived benefits of action,
perceived barriers to action, perceived self-efficacy, activity-related effect, interpersonal
influences, and situational influences all have a direct or indirect effect on the likelihood of
engaging in health-promoting behaviors (Sakraida, 2002). Each of these factors must be
considered when designing, implementing, and evaluating a CRC screening tool.
Pender’s HPM is unique when applied to CRC screening behaviors. Prior related
behaviors may include the frequency with which an individual visits their primary care provider.
Personal factors may include an individual’s family member dying from CRC. Perceived
benefits of action might be early detection of CRC. Perceived barriers to action might revolve
around the sensitive nature of CRC screening. Interpersonal influences might be that an
individual is married to a gastroenterologist who strongly believes in CRC screening.
Nola Pender believes the opportunities for advanced practice nurses in health promotion
are astounding. She believes that NPs must incorporate research findings about health promotion
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into clinical practice, community partnerships, and health promotion programs. She encourages
NPs to understand the dynamics of behavior in order to build effective interventions. (University
of Michigan School of Nursing, 2001)
Health promotion can be carried out on an individual level or a population perspective
(Emmons, 2000). While individually-based interventions may be more effective for high-risk
individuals, population-based efforts are better for health promotion as it relates to widespread
diseases or conditions. Emmons notes that even small changes at the population level can lead to
large effects on disease risk.
Relevant Research Literature
Unmodifiable Risk Factors for Colorectal Cancer
Some individuals are at a higher risk of developing CRC if they have the following risk
factors: a genetic condition such as familial adenomatous polyposis (FAP) or hereditary
nonpolyposis colorectal cancer (HNPCC), a personal history of colorectal cancer or adenomas,
first degree relative with colorectal cancer, first degree relative with adenomas diagnosed before
age 60, a personal history of breast, endometrial, or ovarian cancer, or a personal history of
chronic ulcerative colitis or Crohn’s colitis (National Cancer Institute, 2003). Age is another
unmodifiable CRC risk factor, with 93% of cases occurring in people age 50 and older (Centers
for Disease Control, 2002). Persons in high-risk categories must be referred to a gastrointestinal
specialist for development of an individualized surveillance plan (Radowski, DeDecker, &
Westendorp, 2001).
Modifiable Risk Factors for Colorectal Cancer
Slattery et al. (1999) note that the prevalence of CRC is highest in populations of high
socioeconomic status, possibly as a result of dietary and lifestyle customs. Alberts (2002) adds
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that dietary risk factors for CRC have been identified including eating red meat or any broiled
meat. There are conflicting reports on whether high amounts of dietary fiber reduce the risk of
CRC. Studies show an increased incidence of CRC associated with a diet high in total fat,
protein, calories, alcohol, and meat and low in calcium and folate (Robinson, 2002).
Evidence suggests that 60 minutes of daily vigorous activity may reduce CRC risk by
30% (Slattery et al ., 1997). Obesity with excess fat in the waist area is also associated with an
increased incidence of CRC (Robinson, 2002). Cigarette smoking and high alcohol
consumption, particularly beer consumption linked with rectal cancer, have been linked to
increased risk of CRC (Robinson). Rex (2002) elaborates that previous studies suggest as much
as 20% of colorectal cancer can be attributed to cigarette smoking and that smokers have an
equivalent increased risk to those with a positive family history.
Three Levels of Colorectal Cancer Risk
During the 2001 annual conference of the American Society of Colon and Rectal Surgeons
(ASCRS), three categories of colorectal cancer risk were identified (Simmang et al., 2002).
• Low / average risk: Individuals without symptoms or risk factors and without a firstdegree relatve diagnosed with colorectal cancer belong in this group. This group
represents 65% to 75% of the population.
• Moderate risk: Individuals with a family or personal history of colorectal cancer are in
this group, which comprises 20% to 30% of the population.
• High risk: Individuals with a history of FAP, HNPCC, or ulcerative colitis are in this
group.
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Pathophysiology of Colorectal Cancer
Colorectal cancer follows a multistage development pathway as shown in Figure 1. This
pathway begins with epigenetic events, activation of proto-oncogenes, or inactivation of tumorsuppressor genes (Huether, 2002) . Normal colorectal cells are then mutated as a result of
chemicals, viruses, or radiation. This mutation process genetically alters the cell. The altered
cell experiences clonal expansion and becomes a group of cells called a preneoplastic lesion.
More cellular genetic change leads to a benign tumor, a malignant tumor, and finally clinical
cancer (Huether). The gene most closely linked with CRC is the p53 gene. Altered p53 genes
are present in 85% of CRC cases (Huether).
Adenomatous polyps are the precursor to most colorectal cancers. These polyps are a
direct result of a chromosome five mutation (Huether, 2002). While most polyps are benign,
some are neoplastic and become highly malignant after the mucosa is penetrated. Fortunately,
colorectal adenomas can be detected early since the mucosa may not be penetrated for several
years. Huether notes that the larger the polyp, the higher the risk of colorectal malignancy.
Most colorectal cancers are deemed moderately differentiated adenocarcinomas (Huether,
2002). Colorectal tumors often have a long preinvasive phase and continue to grow slowly after
invasion. CRC tumors must traverse the muscularis mucosae into the lymphatic channels before
metastasis can occur (Huether). When metastasis does occur, the liver is often affected because
the portal vein carries the venous blood flow from the colorectal tumor to the liver (Bliss &
Sawchuk, 2000).
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Epigenetic events, activation of proto-oncogenes, or inactivation of tumor-suppresor
genes
↓
Mutation of normal cell from chemicals, viruses, or radiation
↓
Initiated cell already changed genetically
↓
Clonal expansion leads to precancerous lesion
↓
Genetic changes lead to benign tumor
↓
More genetic changes lead to malignant tumor
↓
Invasion of cancerous cells lead to clinical cancer

Figure 1. Conceptual map of the multistage development of colorectal cancer (Huether,
2002).
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Clinical Manifestations of Colorectal Cancer
Clinical manifestations of CRC vary depending on which section of the colon is affected.
Symptoms can be nonspecific and may not appear until the disease is advanced (Bliss &
Sawchuk, 2000). Symptoms may include: abdominal pain, anemia resulting in weakness and
fatigue, dark red or mahogany-colored blood mixed with the stool or bright red blood on the
surface of the stool, progressive abdominal distention, and change in bowel habits (Huether,
2002). A change in bowel habit consistent with CRC is a stool that is narrower than usual
(Centers for Disease Control, 2002). Late signs of CRC may include: pallor, cachexia,
lymphadenopathy, ascites, and hepatomegaly if the liver is involved (Bliss & Sawchuk).
Rectal bleeding is often under-reported as many patients attribute any presence of blood
to hemorrhoids (Rakowski, DeDecker, & Westendorp, 2001). The American Cancer Society
(ACS) also mentions a feeling that you need to have a bowel movement that is not relieved after
the bowel movement (2003). The ACS adds that the narrow stools must last more than a few
days to be considered a possible symtom of CRC.
Screening Guidelines
There are currently four recommended screening strategies for CRC in average-risk
individuals according to the Agency for Healthcare Research and Quality (Swaroop & Larson,
2002). These strategies are: annual fecal occult blood test (FOBT), flexible sigmoidoscopy (FS)
every 5 years, double-contrast barium enema every 5 to 10 years, and colonoscopy every 10
years (Swaroop & Larson, 2002). The American Cancer Society (2003) recommends that all
people over age 50 have a FOBT every year and a sigmoidoscopy every five years or a
colonoscopy every 10 years. Ideally, the patient and physician choose a test that together meets
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their expectations. However, a patient’s preferred screening option may differ from the preferred
choice of the physician.
New guidelines from the U.S. Multisociety Task Force on Colorectal Cancer recommend
that patients with one or two tubular adenomas less than one centimeter (cm) should have their
first follow-up colonoscopy at five years (Barclay, 2003). Patients with advanced or multiple
adenomas (three or more) should have their first follow-up colonoscopy at three years (Barclay,
2003). The new guidelines also address those with a family history of FAP and encourage
genetic testing and consideration of colectomy. Genetic testing in children can be delayed until
10 years of age. Those with HNPCC should have a colonoscopy every six months to a year
beginning at age 20 to 25 years or 10 years before the youngest cancer diagnosis in the family
(Barclay, 2003).
U.S. Preventive Services Task Force (2002) recommends that patients discontinue CRC
screening when age or comorbid conditions limit life expectancy. Benefits of screening
individuals over the age of 80 may be limited as a result of competing causes of death.
Fecal occult blood testing. The newest guidelines from the U.S. Multisociety Task Force
on Colorectal Cancer encourage annual fecal occult blood testing for people over the age of 50
who fall into the average risk category for CRC (Barclay, 2003). FOBT has shown mortality
reduction and CRC incidence reduction. Each of the screening tools mentioned do have
limitations. One drawback of this test is the different kits used to test stool for occult blood.
Research has shown large variations in results from the Hemoccult test kit versus the
HemoQuant test kit (Barclay).
Medications and food may also affect the FOBT. The American Cancer Society (2003)
suggests that patients follow these guidelines: avoid all non-steroidal anti-inflammatory drugs
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for seven days before testing, avoid vitamin C in excess of 250 milligrams from either
supplements or citrus juices three days before testing, and avoid red meats for three days before
testing. The American Cancer Society adds that a test of a stool sample from a digital rectal
exam is not an adequate substitute. The take-home multiple sample method should be used for
FOBT.
Another drawback with FOBT is compliance. Most patients whose family members have
CRC never seek FOBT screening from their own physicians. Physicians have also found lack of
follow-up from patients whose FOBT tests positive. Even after being notified of the positive
results, patients decide not to come back for further testing. A final drawback with FOBT is that
if the test is positive, further testing (most often colonoscopy) is required to confirm a diagnosis
of CRC (Swaroop & Larson, 2002).
Barium enema examination. Barium enema examinations have not been shown to
decrease CRC mortality or incidence (Swaroop & Larson, 2002). Screening with barium enema
is generally reserved for persons in whom colonoscopy is technically impossible (Radowski,
DeDecker, & Westendorp, 2001). Research has shown that double-contrast barium enemas are
only 48% effective at detecting adenomas greater than 1 cm. Again, further testing (most often
colonoscopy) is required after barium enema examination to confirm a diagnosis of CRC
(Swaroop & Larson).
Flexible sigmoidoscopy. Use of flexible sigmoidoscopy (FS) resulted in a slight decrease
in CRC mortality (Swaroop & Larson, 2002). FS, like the other screening methods, does have its
disadvantages. First, a patient has to cleanse the colon in preparation for FS. Patients do not
always do this properly; this results in inadequate examination. Second, no sedation is given for
FS as this procedure is performed in the physician’s office. This leads to patient discomfort and
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thus poor patient compliance. Third, FS can only detect distal adenomas; proximal adenomas
can not be visualized using FS. Bliss and Sawchuk (2000) state that approximately 50% of
colorectal cancers are out of reach of the sigmoidoscope. Finally, most physicians do not
perform FS routinely. This again leads to inadequate examination and greater risk of missing a
neoplasm (Swaroop & Larson).
Colonoscopy. Colonoscopy as a primary screening strategy for CRC has several
advantages. It has shown a significant decrease in CRC mortality and incidence. It also allows
the physician to visualize the entire length of the colon. There are no further examinations after
colonoscopy; one either has an adenoma or CRC or not. It may be more cost-effective due to its
ability to diagnose with a single exam and thus only one visit. It only needs to be performed
every 10 years in average-risk individuals, whereas other tests such as FOBT are recommended
annually. Patients prefer colonoscopy because a sedative is administered; this increases patient
comfort and thus patient compliance and satisfaction. Colonoscopy, as with any invasive
procedure, does have a risk for complications. Bleeding occurs in approximately 0.2% of cases
and perforation of the colon occurs in approximately 0.1% of cases(Swaroop & Larson, 2002).
Swaroop and Larson (2002) make a strong case for colonoscopy as the primary screening
strategy for CRC. It has been shown to be an effective diagnostic tool. Colonoscopy may be
performed in a hospital outpatient department, in a clinic, or in a doctor’s office. It usually takes
15-30 minutes unless polypectomy is required (American Cancer Society, 2003). It is also costeffective, and patients prefer it. Rakowski, DeDecker, & Westendorp (2001) state that the
colonoscopy may decrease the incidence of CRC by 76 to 90 percent.
Virtual colonoscopy. Virtual colonoscopy is actually a special computerized tomography
(CT) scan of the colon. The preparation for this exam is the same as for barium enema or
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colonoscopy. Air is pumped into the colon to distend it before it is scanned. While this exam
may be more accurate than the barium enema, it is not as thorough as a colonoscopy (American
Cancer Society, 2003). Its advantages are that it can be done quickly, without sedation, at a
lower cost than colonoscopy (American Cancer Society). However, if a polyp or growth is
found, a colonoscopy will be required to remove those growths. ACS does not currently
recommend virtual colonoscopy for early detection of CRC.
Swallowable camera. In August 2001, the United States Food and Drug Administration
approved a swallowable camera that detects polyps and cancers in the small intestine. This
device allows for examination by taking pictures every 30 seconds of the gastrointestinal tract.
As it exists now, this pill is not useful in detecting colorectal cancer. One reason is that its
battery only lasts eight hours, which is not enough time to photograph the entire gastrointestinal
tract. Another reason is that the colon is so large in relation to the pill that parts of the colon
would be missed during its photographic journey. (Cancer Research and Prevention Foundation,
2003)
Analysis of minichromosome maintenance proteins in stool. Davies et al. (2002)
conducted a clinical evaluation study in which minichromosome maintenance protein 2 (MCM2)
was analyzed in stool specimens from patients with symptomatic colorectal cancer and from
healthy control patients. Thirty-seven of 40 patients with CRC had MCM2 cells in their stool
specimens, while none of the healthy 25 control subjects had MCM2 cells in their stool. These
results are promising for future research on detecting CRC from a non-invasive approach, the
stool specimen (Davies et al., 2002).
DNA stool test. There are ongoing trials for a new DNA stool test which shows greater
sensitivity than FOBT but less than that of colonoscopy (Barclay, 2003). One such trial is
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intended for use in average-risk individuals who decline colonoscopy. Early results confirm that
this test will be superior to FOBT but inferior to colonoscopy as predicted (Rex, 2002).
Bowel symptoms assessessment questionnaire (BSAQ). Selvachandran et al. (2002)
describe a practical scoring method to predict colorectal cancers. This score (the Selva score)
was developed in early 1999 by S. N. Selvachandran and derived subjectively based on clinical
experience. These researchers administered a questionnaire, the BSAQ, to 2268 patients who
were referred to surgeons by their general practitioners for distal colonic symptoms. Referrals
were prioritized with a malignancy risk score (different from the Selva score) by a senior
colorectal surgeon separately from the risk score of the questionnaire. The two scoring systems
(Selva score versus surgeon’s priority score) were then compared after colonoscopy revealed
cancer rates in these patients. Results showed that the two systems in conjunction could be used
as an accurate system for prediction of symptomatic colorectal cancer.
Other colorectal screening programs. Burke et al. (2002) conducted a study to evaluate
the long-term effects of a colorectal screening program. Burke et al. targeted women’s interest
in CRC screening, since women often direct the health care of the family and the community.
Burke et al. recognized that most women already participate in routine breast and cervical cancer
screenings. Results of the study suggest that individuals involved in a CRC screening program
are more likely to continue with future screenings, even in average-risk populations.
Harris, Byles, Cockburn, and D’Este (2000) evaluated a general practice-based
recruitment strategy for colorectal screening. Thirty general practitioners (GPs) volunteered to
be part of a CRC screening trial in New South Wales. The GPs had a total of 303 patients who
reported a family history of CRC; 158 were placed in the intervention group and 145 were placed
in the control group. The intervention consisted of those patients being given a pamphlet
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detailing CRC risk factors and screening tests; the pamphlet had a tear-off page requesting FOBT
be given to the patient. Results showed that 18% of patients in the intervention group requested
the FOBT screening while only 6% of patients in the control group requested FOBT screening.
Harris et al. concluded that a pamphlet by itself was a weak intervention.
Prevention of colorectal cancer
Chemoprevention of colorectal cancer. In addition to surveillance, chemoprevention is
another option for reducing the incidence of colorectal cancer. Alberts (2002) identifies the aim
of chemoprevention as using noncytotoxic nutrients and/or drugs to circumvent the development
or progression of precancerous cells. Promising agents being studied in clinical trials include
nonsteroidal anti-inflammatory drugs (NSAIDs) such as Aspirin and Sulindac, non-NSAIDs
(Folic acid, Selenium, Curcumin, Calcium carbonate, and Difluoromethylornithine), and
NSAID-related drugs (Celecoxib, Rofecoxib, and Exisulind). Studies show that regular
ingestion of aspirin and NSAIDs can produce a 30% to 50% reduction in incidence and mortality
of CRC after at least five years of continuous use (Roy, 2002).
Lifestyle changes. Bennett (2002) discusses some lifestyle changes that may reduce the
risk of developing CRC. These include taking a multivitamin containing folic acid every day,
exercising for at least 30 minutes daily, eating less red meat, avoiding smoking, and reducing or
eliminating alcohol consumption.
The Future of Colorectal Cancer Screening
The Center for Disease Control (2003) developed a comprehensive CRC initiative
designed to increase public awareness of CRC, increase PCP awareness of CRC screening
guidelines, promote improved patient-provider communication about CRC screening, support
CRC research, and provide funding to state programs to implement CRC priorities. The CDC is
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using these efforts to reach a goal of the national health objectives for 2010: to reduce the CRC
death rate.
Gaps in the Knowledge
Despite an increase in public awareness of colorectal cancer and Medicare
reimbursement for screening, colorectal cancer screening rates remain low (Barclay, 2003).
Bliss and Sawchuk (2000) note that although participation in early cancer screening is effective
in decreasing mortality, fear of diagnosis may exist as a barrier.
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CHAPTER 3
Methods and Procedures
Introduction
This section describes the research design, sample, setting, instrument and measurement
methods, data collection procedures, and ethical considerations for this study. Rationale for
chosen methodologies are included from the literature.
Research Design
A correlational, replication research design was used in this study. Correlational research is
designed to determine a relationship between two variables; if a correlation is found, an outcome
can be predicted (University of Georgia, 2002). For this study, a Selva score computed from the
Bowel Symptoms Assessment Questionnaire (BSAQ) was compared to the colonoscopy results
(presence or absence of CRC) of participants (Selvachandran et al ., 2002). A point biserial
correlation coefficient was calculated to determine the strength of the relationship between the
Selva score and the presence of colorectal cancer (CRC). Even though this study was completed
in England, predictive studies must be repeated to apply results to different groups (California
State University Fullerton, 2001). Furthermore, statistical predictions based on correlations have
been shown to be superior to predictions formed from clinical experience (Shaughnessy &
Zechmeister, 2002).
Sample
A purposive convenience sample of patients scheduled for routine colonoscopies was used.
Only individuals under the age of 18 and emergent colonoscopy patients were excluded from this
study.
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Based on a power analysis, the sample size for this study needed to be 392. A power
level of 0.80, and alpha level of 0.05, and a moderate effect size were used in the power analysis
formulas developed by Cohen (Polit & Hungler, 1999). Selvachandran et al. (2002) used a
sample size of 2268 patients over a two-year study period.
Setting
This study was conducted in the endoscopy area of the outpatient department of a 211bed for-profit hospital (see Appendix B for letter of permission). Selvachandran et al. (2002)
used a similar setting in England and had no subjects refuse or withdraw. Since the hospital’s
endoscopy suite performs only 1000-1500 routine colonoscopies a year (G. Easton, personal
communication, April 7, 2003), this setting did not provide access to the appropriate number for
this study’s sample.
Instruments
Description of the Instrument
The BSAQ is a questionnaire developed by Selvachandran et al. in 1999 (see Appendix
C). The questionnaire was tested in a two-year study involving 2268 patients with distal colonic
symptoms in England. The BSAQ consists of 33 items that are measured using a weighted
numerical score. This score (the Selva score) was developed in early 1999 by S. N.
Selvachandran and derived subjectively based on clinical experience. The questionnaire
examines topics such as age, sex, rectal bleeding, changes in bowel habits, perianal symptoms,
abdominal symptoms, weight loss, loss of appetite, fatigue, family history, and relevant medical
history (Selvachandran et al ., 2002). Selvachandran et al. reported high levels of reliability
(specific reliability measures were not discussed) with their 1999-2001 study.
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The BSAQ is written at the sixth-grade reading level. Instructions for use are clearly
written at the top of the BSAQ. Scoring occurred using a software program, the Medical
Adaptable Audit Base Systems (MAABS), also developed by Selvachandran. Permission to use
the BSAQ was obtained via electronic mail with David Cade (see Appendix C). The level of
measurement obtained from each item on the BSAQ was be nominal. The Selva score itself was
be ratio level data.
Administration and Scoring
All six of the endoscopy nurses met with the researcher for about thirty minutes to
discuss the research project, administration of the questionnaires, and informed consent before
any data collection began. A paper and pencil questionnaire was administered to patients in the
endoscopy area of the hospital. After obtaining informed consent (see Appendix D), the patient
was asked to complete the questionnaire (see Appendix E). A nurse was available for assistance
if the patient had questions or was functionally illiterate. Each nurse received prior training by
the researcher in ways to avoid leading the patient to a certain answer. The completed BSAQs
were stored in a locked filing cabinet in the endoscopy unit and given to the researcher weekly
during the duration of the study. The collaborating researchers in England entered the answers
from the BSAQs into the MAABS software provided. A paper copy of the data was kept as well
as a computer disc back-up of all data. Results were shared with Selvachandran et al. at the
completion of the study.
Burns and Grove (2001) defines measurement error as the difference in what exists in
reality and what the research instrument measured. Strategies to decrease measurement error in
this study included training of endoscopy nurses before data collection begins, providing a
comfortable room and adequate time for participants to complete the BSAQ, using only one
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researcher to enter data into the MAABS, consistently and routinely checking for errors in
administration and scoring, and consulting a statistician to make suggestions before data
collection begins.
Data Collection Procedures
The researcher met with staff of the endoscopy area before beginning data collection. All
endoscopy nurses were trained on administering the questionnaire and storing the completed
BSAQs. Endoscopy nurses approached patients in the endoscopy area, obtained consent, and
administered the questionnaire to patients waiting for their colonoscopy exam. The collaborating
researchers in England entered all data into the MAABS software. A flow chart of the data
collection process was used (Appendix F). The data was kept in a faculty sponsor’s office under
a double-lock system. Only initials and medical record numbers were used to identify
participants in order to maintain confidentiality.
The researcher needed and received full cooperation from Greenview Regional Hospital
to meet the goals of this study. Staff, physician, and agency cooperation were essential to the
success of this project. The researcher made herself available to those who were involved in this
study via telephone, electronic mail, and personal visits to the endoscopy unit.
Data Analysis
Descriptive statistics and chi-square analysis was performed on data such as rectal
bleeding, abdominal pain, change in bowel habit, and age using SPSS software. These
calculations addressed research objective one.
Welkowitz, Ewen, and Cohen (2000) suggest using the point biserial correlation
coefficient (rpb) when exploring the relationship between a continuous variable (Selva score) and
a dichotomous variable (presence or absence of colorectal cancer). The point biserial correlation
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coefficient tests for statistical significance in the same manner as the Pearson r. These
calculations addressed the second and third research objectives.
Ethical Considerations
Following approval from the thesis committee, the Western Kentucky University Human
Subjects Review Board (HSRB) was asked to grant approval of this study before data collection
began (see Appendix G). The endoscopy nurses asked each participant to sign an informed
consent form as well as a medical record release form from the hospital to allow access to
colonoscopy results of the participants.
The only risks the subjects may have endured were the inconvenience or the time involved
in answering the questionnaire and possibly mild discomfort due to the sensitive nature of the
questions. If a patient appeared to be extremely nervous about the colonoscopy, the endoscopy
staff chose not to approach that patient. There was no criteria for anxiety level; this was
according the endoscopy nurse’s instincts. This researcher did not intend to increase the
subject’s level of anxiety about their medical procedure.
Although there were no known direct benefits to participants, the indirect benefits were
potentially notable. This research may eventually lead to earlier referral, earlier diagnosis, and
earlier treatment of CRC. Individuals involved in a CRC screening program are more likely to
continue with future screenings, even in average-risk populations (Burke et al., 2002). Screening
has been shown to reduce CRC-related morbidity and mortality (Stoffel & Syngal, 2002).
Colorectal cancer screening has also been shown to be as cost-effective as screening
mammography (Winawer & Zauber, 2000).
As this non-invasive approach to CRC screening receives more attention from the media
and medical community, patients and community members may begin to recognize the early
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warning signs of CRC. This increased awareness and knowledge of risk factors could lead to
earlier reporting of symptoms to primary care providers as well as lifestyle modifications. Nurse
practitioners could also encourage other members of the medical community to follow CRC
screening guidelines and to stress the importance of colorectal health to their patients.
Dissemination
A formal presentation of the results of this study was given by the researcher on April 29,
2004 for all faculty of Western Kentucky University College of Health and Human Services.
Results will be presented at Annual Research Day of the Kappa Theta chapter of Sigma Theta
Tau, International in Bowling Green, Kentucky in November 2004.
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CHAPTER 4
Results
Introduction
The purpose of this correlational, replication study was to determine whether symptoms
such as rectal bleeding, change in bowel habit, and abdominal pain are associated with
symptomatic colorectal cancer using a sample of individuals scheduled for a routine
colonoscopy. Data obtained from 47 BSAQs given to subjects undergoing routine colonoscopy
at Greenview Regional Hospital in Bowling Green, Kentucky were analyzed to address the
research objectives of the study. Additional findings, limitations, and implications for future
research are discussed in conjunction with the results of the data analysis.
Sample Demographics
A sample of 47 patients waiting for their routine colonoscopy was obtained during the
months of August, September, October, and November 2003. There were 25 males and 22
females. Ages ranged from 27 to 76, with a mean age of 56.13 and a standard deviation of
11.34.
Objective One
The first objective of this study was to identify variables associated with colorectal
cancer using a questionnaire administered to patients with distal colonic symptoms. Based on an
extensive literature review, variables such as rectal bleeding, change in bowel habit, and
abdominal pain are all symptoms of CRC. None of the patients had CRC, but 15 had polyps.
Since polyps are a precursor to CRC, variables were linked to the presence of polyps (see Tables
1, 2, and 3).
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Table 1
Change in Bowel Habit and Polyps
Yes Polyps

No Polyps

Total

Change in BM

4

10

14

No Change in BM

10

22

32

Total

14

32

46

Yes Polyps

No Polyps

Total

Yes Bleeding

4

12

16

No Bleeding

11

20

31

Total

15

32

47

Table 2
Rectal Bleeding in Polyps

Table 3
Abdominal Pain and Polyps
Yes Polyps

No Polyps

Total

Yes Pain

7

14

21

No Pain

7

17

24

Total

14

31

45
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The ages of patients with polyps ranged from 42 to 72 with a mean age of 54.87; 4 of the
15 patients with polyps were under the age of 50. This is interesting since the American Cancer
Society (2003) does not recommend routine screening to low-risk individuals until the age of 50.
Of those four patients, two had a family history of colon cancer, but two did not.
Chi-square (χ2) analysis was performed on the variables: rectal bleeding, change in
bowel habit, and abdominal pain as they related to the presence or absence of polyps. Chi-square
analysis was attempted on the relationship of polyps to the following variables: age, rectal
bleeding, change in bowel habit, and abdominal pain. Chi-square could not be performed on
bowel habit or rectal bleeding due to a cell frequency of 4 (no less than 5 is expected in a 2x2
table). Chi-square for abdominal pain and polyps was 0.09. For significance at the .05 level, this
distribution was not significant.
A t-test was performed on the following means of the two groups (polyps versus no
polyps): Selva score, age, rectal bleeding, change in bowel habit, and abdominal pain. T-tests of
the means of the polyp group versus the no polyp group showed no difference between the
population means for each of these variables.
Objective Two
The second objective of this study was to determine a patient’s malignancy risk score
(Selva score) using the data obtained in the questionnaire. The mean Selva score for the 32
patients without polyps was 25.44. The mean Selva score for the 15 patients with polyps was
26.13. Selva scores ranged from 4 to 60.
Objective Three
The third objective of this study was to evaluate the relationship between the Selva score
and the presence or absence of colorectal cancer based on pathology results from a colonoscopy.
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This was originally going to be analyzed using the point biserial correlation coefficient (rpb) by
exploring the relationship between a continuous variable (Selva score) and a dichotomous
variable (presence or absence of colorectal cancer). The point biserial correlation coefficient
tests for statistical significance in the same manner as the Pearson r. Since there were no
subjects with CRC in this study, the Selva score was related to the presence or absence of polyps.
The point biserial correlation (rpb) coefficient for Selva scores in relation to the presence
or absence of polyps was +0.02. This means approximately 2% of variability in polyps is
predicted by Selva score. Thus, there was no relationship between the Selva score and the
presence or absence of polyps.
Hypotheses
The research hypothesis for this study was that the questionnaire will show a significant
level of predictiveness for symptomatic colorectal cancer (based on the results of the point
biseral correlation coefficient). The null hypothesis for this study was that there will be no
relationship between the Selva score generated by the BSAQ and the incidence of colorectal
cancer in patients scheduled for a routine colonoscopy (also based on the results of the point
biseral correlation coefficient). Since none of the patients in the study had colorectal cancer, the
researcher could not evaluate either hypothesis.
Summary
None of the 47 patients in this study had colorectal cancer, however nearly 1/3 of the
patients had one or more polyps. According to chi-square analysis, rectal bleeding, abdominal
pain, and change in bowel habit did not have a significant relationship to polyps. T-tests of the
means of the polyp group versus the no polyp group showed no difference between the
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population means for each of the above variables. The patients’ Selva scores ranged from 4 to
60. Selva scores did not have a significant relationship to the presence of polyps.
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CHPTER 5
Discussion
Introduction
Notable findings and conclusions are discussed in regard to the study’s research
objectives. Strengths and limitations of the research are identified as well as implications for
future research.
Discussion of Findings
While none of the patients had CRC, 15 of the 47 patients (32%) had polyps. Polyps are
a known precursor to CRC, so relationships between polyps and CRC symptoms were examined.
Selva scores were also compared to the presence or absence of polyps. The mean Selva score for
the 32 patients without polyps was 25.44. The mean Selva score for the 15 patients with polyps
was 26.13. While the polyp group had a slightly higher mean Selva score, there was no
statistical difference between groups. Selva scores ranged from 4 to 60.
Selvachandran et al. (2002) had 95 patients with CRC out of a sample of 2268 patients.
Patients with CRC had a mean Selva score of 76.5, while patients without CRC had a mean
Selva score of 44.5. Selvachandran et al. noted that patients with colitis or large polyps had
higher Selva scores than most patients who did not have CRC. Based on these results,
Selvachandran et al. determined that a Selva score above 70 shows a cancer risk of one in five,
while a Selva score under 40 has a cancer risk of one in 967. These Selva score guidelines hold
true for the results in this study since no patients had a Selva score above 60 and no patients had
CRC.
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Framework
Nola Pender’s Health Promotion Model (HPM) was used as the framework for this
research. Prior related behavior, personal factors, perceived benefits of action, perceived barriers
to action, perceived self-efficacy, activity-related effect, interpersonal influences, and situational
influences all have a direct or indirect effect on the likelihood of engaging in health-promoting
behaviors such as CRC screening.
It is interesting to note the differences in Selva scores between the England study and this
study in the United States. Patients in the U.S. who did not have CRC had a mean Selva score of
25.44 (without polyps) or 26.13 (with polyps), while patients in England who did not have CRC
had a mean Selva score of 44.5. This could be due to the small sample size in the American
study, or it may be linked to health-promotion behaviors of Americans. Perhaps Americans are
being screened for CRC when they have much fewer symptoms and risk factors than English
patients.
Strengths
Instrumentation
Since this is a replication study, the instrument (BSAQ) has been used in previous
studies. Reliability and validity for the BSAQ has been established and documented, although
specific values were not discussed (Selvachandran et al., 2002). The BSAQ also allows the
researcher to analyze relationships among a large number of variables in a single study.
LaMar (2002) explains one problem with the interpretation of correlational research. This
problem relates to a large number of variables being measured and analyzed without justifiable
rationale for their inclusion. Lamar (2002) goes on to say that preliminary research to establish
that the variables in a study are relevant to its purpose may help researchers avoid this problem.
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The literature review for this study supports that the variables are relevant to the purpose of the
study.
Swaroop and Larson (2002) identified several risk factors for CRC. Age (above 50),
family history of CRC or adenomas, adenomatous polyposis coli, personal history of adenomas
or CRC, and inflammatory bowel disease are all risk factors for CRC. Selvachandran et al.
(2002) found that rectal bleeding and change in bowel habits to looser, more frequent stools had
the highest relative-risk ratios for CRC. Each of these variables is included in the BSAQ
(Selvachandran et al ., 2002).
Data Collection
Reliable data collection methods were enhanced through intrarater reliability. Intrarater
reliability, or unitizing reliability, refers to the ability of the researcher to code similar events the
same way every time they are observed (Burns & Grove, 2001). Again, this was not an issue
since this was not an observational study and answers from the BSAQ were simply entered into
the MAABS software. Even though there were several nurses distributing the BSAQ, the
patients were able to complete the form with minimal to no assistance. As previously
mentioned, all six endoscopy nurses received the same verbal training on administering the
BSAQ by the primary researcher.
Medical Records
One strength of this study was the completeness of the medical record. Thanks to the
cooperative staff at Greenview’s Medical Records Department, the researcher was able to obtain
100% of the operative and pathology reports needed for this study.
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Limitations
Sampling Method
Correlational research runs the risk of not being able to eliminate confounding variables
(University of Georgia, 2002). For example, a patient with Crohn’s disease may score a high
Selva score from the BSAQ but have no evidence of colorectal cancer. However, a Crohn’s
disease sufferer will often be scheduled for a routine colonoscopy. Such results may skew the
findings of this study. There was one patient who had a diagnosis of Crohn’s disease.
Another weakness revolves around purposive sampling. There is no guarantee that every
individual in the population has an equal chance of being included in the sample when purposive
sampling is employed (Shaughnessy & Zechmeister, 2002).
Sample size
Also, another limitation of this study was the small sample size. Based on the power
analysis, 392 subjects were needed for this study. Only 47 subjects were recruited during the
three-month data collection period. Since the primary researcher was unable to personally
collect the data, she entrusted the data collection to six registered nurses at the data collection
site. Although the nurses reported to the researcher each week when completed questionnaires
were picked up from the data collection site, the researcher questioned why such a small sample
was obtained. The nurses reported that certain weeks were busier than others, which limited
their time to obtain informed consent and allow the patients to complete the questionnaires. The
nurses also reported that some patients were too anxious about the procedure to participate in the
study.
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Instrumentation
As previously discussed in Chapter 3, the instrument (BSAQ) includes questions that are
subjective in nature, which may threaten internal validity. What one individual considers to be a
“small amount” of blood may be considered a “large amount” of blood by another individual. It
was noted that a few BSAQs were not entirely completed. This missing data may have been due
to lack of understanding of the questions or the sensitive nature of the questions. It did not
appear that any of the subjects ran out of time to complete the BSAQ, because the questions left
blank were not on the last page of the questionnaire.
Although Selvachandran et al. reported high levels of reliability (specific reliability
measures were not discussed) with their 1999-2001 study (Selvachandran et al ., 2002) , this does
not guarantee satisfactory reliability in samples of a different population (Burns & Grove, 2001).
California State University Fullerton (2001) gives reasons why accuracy may be decreased in a
predictive study. A few reasons mentioned are unreliable variables, length of time between data
collection of predictor and criterion variables, and the broadness of the criterion. Unreliable
demographic variables may have existed in this study such as those individuals who had no distal
colonic symptoms but decided to undergo colonoscopy because their neighbor just passed away
as a result of CRC.
Data Analysis
Since the primary researcher was collaborating with researchers in England, the data
analysis that addressed research objectives two and three involved the Selva score. This score
can only be calculated through the MAABS software provided by Selvachandran et al (2002).
During the data collection process, the primary researcher was informed by her partners in
England that they preferred to enter the data into their software and provide Selva scores to the
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researcher instead of sending the researcher the MAABS software. Once data collection was
complete, the primary researcher made copies of the completed BSAQs, operative reports, and
pathology reports and mailed them to England as allowed in the informed consent. This left part
of the data analysis out of the researcher’s control.
Implications for Future Research
This study provides several implications for future research. First, this study could be
replicated and include a much larger sample size. A larger sample size would increase the
likelihood of subjects having colorectal cancer, thus allowing the study’s original intent to be
carried out. The Selva score could then be compared with the presence or absence of CRC,
instead of with the presence or absence of polyps.
Second, the BSAQ could be used in the primary care setting. If primary care providers
administered the BSAQ to all patients with CRC risk factors or over the age of 50, symptoms of
CRC might be recognized earlier. This might lead to earlier referral, diagnosis, and treatment.
Implications for Advanced Nursing Practice
Advanced registered nurses such as nurse practitioners and nurse educators can gain
knowledge from this study. First, knowing the background and significance of CRC might
encourage NPs and nurse educators to discuss CRC with their patients, students, and colleagues.
Second, understanding the strengths and weaknesses of various screening options as well as the
American Cancer Society screening recommendations will help them provide better patient care,
patient education, and nursing education. Finally, recognizing the sometimes vague symptoms
associated with CRC may lead to earlier screening, diagnosis, and treatment.
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Conclusions
This study explored the controversial topic of colorectal cancer screening, utilizing a noninvasive self-report screening tool. Symptoms of CRC were identified and evaluated with the
BSAQ. Results of the BSAQ were then compared with results of the colonoscopy on the 47
subjects involved in this study. Although no subjects had CRC, 15 subjects had polyps. Despite
a lack of significant findings, this research has implications for advanced practice nursing as well
as for future research. If the nursing community can embrace and continue this research, perhaps
CRC will no longer be the second leading cause of cancer deaths in the United States.
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APPENDIX A
Nola Pender’s Health Promotion Model
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APPENDIX B
Copy of Electronic Mail from Sharon Moore received on July 14, 2003
Dear Amy,
>
> Your request to have Greenview participate in your research study has been
> approved. We'll send you an official letter tomorrow authorizing you to ask
> endoscopy patients to participate in your study providing necessary medical
> records release forms and consent forms are documented.
>
> Would you be so kind as to email me back with your correct mailing address
> or shall we send the letter to WKU?
>
> Thank you.
> Sharon J. Moore
> Administrative Assistant
> for Sherry McDonald, RN Chief Nursing Officer
> Greenview Regional Hospital
> 270-793-5105 phone
> 270-793-5205 fax
> http://www.GreenviewHospital.com
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APPENDIX C
Copy of Electronic Mail from David Cade received on February 17, 2003

Dear Amy,

Thanks for your email. As yet we do not have studies ongoing in the
USA. We would be very happy for you to be involved. Would the study be in
Primary or Secondary care? How many clinicians are likely to be involved?
You would need to send details of sites and clinicians to customise the
program. We have a number of sites in the UK using the system and many more
who are interested. Eventually it will need to be linked to a commercial
outfit as the requests are outstripping our ability to cope, and we have
many other interrelated projects on the go.

David
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APPENDIX D
Informed Consent Document (Western Kentucky University, 2002)
Project Title: Colorectal Cancer Screening: A Noninvasive Approach
Investigator: Amy Frazier, Department of Nursing, (270) 542-4409
136 Landrum Road, Auburn, KY, 42206
You are being invited to participate in a project conducted through Western Kentucky University
and Greenview Regional Hospital. The University and Greenview Regional Hospital require
that you give your signed agreement to participate in this project.
A nurse will explain to you in detail the purpose of the project, the procedures to be used, and the
potential benefits and possible risks of participation. You may ask him/her any questions you
have to help you understand the project. A basic explanation of the project is written below.
Please read this explanation and discuss with the nurse any questions you may have.
If you then decide to participate in the project, please sign on the last page of this form in the
presence of the person who explained the project to you. You should be given a copy of this
form to keep.
1.

Nature and Purpose of the Project:
The purpose of this study is to determine whether a questionnaire is
predictive of colorectal cancer.

2.

Explanation of Procedures:
The research procedure involves answering questions about your symptoms. This
process should only take about five minutes of your time. If you choose not to participate
in the study, there will be no effect on your services here at Greenview Regional Hospital
or any current or future endeavors with Western Kentucky University.

3.

Discomfort and Risks:
There should not be any discomfort associated with this questionnaire process. The
only identified risk is that it will take about five minutes of your time.

4.

Benefits:
The benefits of this research project apply to the future of colorectal screening and
prevention. Earlier referral, diagnosis, and treatment of colorectal cancer are the ultimate
goals of this project. You may not have any direct benefit.

5.

Confidentiality:
Your initials and your medical record number will be linked to these data your
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colonoscopy results for identification purposes only. After they are matched, your initials
and medical record number will be removed and replaced with a numerical code. The data
will then be entered into a computer, identified only by the numerical code. When the data
are analyzed, there will be no names on the data. This identifying data will not be used
when this report is published or discussed. Only the persons involved in data collection
and analysis will see these results. The data will be stored in a locked file cabinet behind a
locked door after it is obtained. This data may be shared with researchers in England who
created the questionnaire.
6.

Refusal/Withdrawal:
Refusal to participate in this study will have no effect on any future services you may be
entitled to from the University or Greenview Regional Hospital. Anyone who agrees to
participate in this study is free to withdraw from the study at any time with no penalty.

If you have any questions about this research study, please contact Amy Frazier, home phone
(270) 542-4409, work phone (270) 796-6298. You may also contact the faculty sponsor for this
research study: Donna Blackburn, Ph.D., office phone 745-3579. For further information
regarding this project, please contact Dr. Phil Meyers, Human Protections Administrator at
(270) 745-4652 or Ms. Steva Kaufman, Compliance Specialist at (270) 745-4652.
You understand also that it is not possible to identify all potential risks in an experimental
procedure, and you believe that reasonable safeguards have been taken to minimize both the
known and potential but unknown risks.
__________________________________________
Signature of Participant
__________________________________________
Witness

_______________
Date
_______________
Date

THE DATED APPROVAL ON THIS CONSENT FORM INDICATES THAT
THIS PROJECT HAS BEEN REVIEWED AND APPROVED BY
THE WESTERN KENTUCKY UNIVERSITY HUMAN SUBJECTS REVIEW BOARD
Dr. Phillip E. Myers, Human Protections Administrator
TELEPHONE: (270) 745-4652
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APPENDIX E
Bowel Symptoms Assessment Questionnaire
(used with permission from David Cade of Mid Cheshire Hospitals in England)
Patient’s Sticker
Please place an “x” in the most appropriate answer box.
1. HAVE YOU HAD ANY RECTAL BLEEDING?
If “YES”, continue below. If “NO”, go to question 2.
A. State whether the blood is

B. Is the blood

Yes □

No □

Fresh or Bright
Old or Dark
Both Fresh & Old

□
□
□

Seen on tissue only
Separate from stool
Mixed with stool
Separate and Mixed in stool
Uncertain separate or mixed

C. When you see blood in stool, is it

Small amount
Large amount

□
□
□
□
□
□
□

D. How often have you seen blood when having a bowel movement?
Everyday
□
Every few days
□
Every week □
Every few weeks
□
Every month □
Every few months
□
Only once or twice in the past year □
E. How long have you been noticing blood with your bowel movements?
Less than four weeks □
1-3 months □
4-6 months
□
6-12 months □
1-2 years
□
Over 2 years □
F. Since you were referred to the hospital, has the bleeding
Gotten worse
□
Improved
□
Remained the same □
Completely stopped □
2. WHAT HAS BEEN YOUR NORMAL BOWEL HABIT? (prior to any recent change)
Normal bowel movement
□
Diarrhea
□
Constipation (less frequent and harder stools)
□
Alternating diarrhea and constipation
□
How often do you normally have a bowel movement?
Once a day
□
Once in few days
2-3 times per day
□
Once a week

□
□
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Varies few times a day to every few days

□

3. DO YOU HAVE ANY CHANGES IN YOUR BOWEL HABIT?
If “YES” continue below. If “NO”, go to question 4.
A. If you have change in your bowel habit…
Diarrhea
□
Constipation (less frequent and harder stools)
□
Alternating diarrhea and constipation
□
Normal motion or stools
□

Yes □

No □

B. Do you have bowel movements more frequently than normal to you?
Yes □
No □
2-4 times more per day
□
5-6 times more per day
□
7-10 times more per day
□
C. Is the increase in bowel movements worse at any particular time of day?
Yes □
No □
Morning
□
Night □
D. Do you have to “rush” to have a bowel movement?
E. How long have you had these symptoms?
Less than four weeks
□
4-6 months
□
1-2 years
□

Yes □

No □

1-3 months □
6-12 months □
Over 2 years □

F. Since you were referred for a colonoscopy, has the change in bowel habits
Gotten worse
□
Improved
□
Remained the same □
Completely stopped □
4. Do you see
Slime (jelly-like fluid) in your stools
Slime and blood in your stools

Yes □
Yes □

No □
No □

5. After a bowel movement, do you feel that you have NOT emptied your bowels
satisfactorily?
Yes □
No □
6. Do you have pain in your tummy (abdomen)?
Yes □
No □
If “YES”, continue below. If “NO” go to question 7.
Lower tummy pain
□
Spasms of tummy pain
□
Left sided tummy pain or discomfort □
Right sided tummy pain / discomfort □
Pain all over the tummy
□
7. Do you have symptoms around your rectum?
Yes □
No □
If “YES” continue below. If “NO” go to question 8.
Pain during a bowel movemet □
Lump or swelling at the rectum
□
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Irritation and itching

□

Leakage or soiling from the rectum □

8. Have you lost weight recently?
Over 10 pounds in three months without trying
Weight loss does not concern you
Due to dieting

Yes □

No □

9. Have you had a decrease in appetite?

Yes □

No □

10. Have you been excessively tired recently?

Yes □

No □

□
□
□

11. Do you take regular medications?
Yes □
No □
If “YES” continue below. If “NO” go to question 12.
Iron tablets
□
Steroids / Prednisone tablets □
Medication for diabetes
□
Blood thinners / Coumadin □
Any other medications (please list)__________________________________
______________________________________________________________
______________________________________________________________
12. Have you had any of these illnesses in the past?
Yes □
No □
If “YES” continue below. If “NO” go to question 13.
Bowel / Colon polyps
□
Colitis (inflammation of the bowel)
□
Cancer
□
If you have had cancer, in which part of the body? ____________________________
13. Have any of your close blood relatives had cancer?
Yes □
No □
If “YES” continue below. If “NO” go to question 14.
*When stating grandparents, aunts, or uncles, please indicate father’s or mother’s side.*
Relation *
Age when cancer was found
Part of the body

14. Please give us any other information that you think may be relevant.
___________________________________________________________
___________________________________________________________
___________________________________________________________
___________________________________________________________
Signature___________________________Date__________________
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APPENDIX F
Flow Chart of Data Collection Process
Patient scheduled for routine colonoscopy enters endoscopy area of the outpatient department at
Greenview Regional Hospital
↓
Endoscopy nurse approaches patient about study, receives informed consent, and gives patient
the BSAQ
↓
Patient completes the BSAQ (with assistance of nurse if necessary) and returns BSAQ to nurse
↓
Nurse files BSAQ into researcher’s locked box through the small opening on the top of the box
in the endoscopy area
↓
Researcher retrieves completed BSAQs once a week
↓
Researcher enters BSAQ responses into MAABS weekly
↓
Researcher takes BSAQs to faculty sponsor’s office weekly after coding them into the MAABS
software

*Colonoscopy results of participants are reviewed and recorded into researcher’s computer
database as available and placed in faculty sponsor’s office as available *
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APPENDIX G
Human Subjects Review Board Letter of Approval
WESTERN KENTUCKY UNIVERSITY
Human Subjects Review Board
Office of Sponsored Programs
104 Foundation Building
270-745-4652; Fax 270-745-4211
E-mail: Phillip.Myers@Wku.Edu
In future correspondence please refer to HS04-004, July 18, 2003
Amy Frazier
136 Landrum Road
Auburn, KY 42206
Dear Amy:
Your research project, “Colorectal Cancer Screening: A Noninvasive Approach,” was
reviewed by the HSRB and it has been determined that risks to subjects are: (1) minimized and
reasonable; and that (2) research procedures are consistent with a sound research design and do
not expose the subjects to unnecessary risk. Reviewers determined that: (1) benefits to subjects
are considered along with the importance of the topic and that outcomes are reasonable; (2)
selection of subjects is equitable; and (3) the purposes of the research and the research setting is
amenable to subjects’ welfare and producing desired outcomes; that indications of coercion or
prejudice are absent, and that participation is clearly voluntary.
1. In addition, the IRB found that: (1) signed informed consent will be obtained from
all subjects. (2) Provision is made for collecting, using and storing data in a manner that protects
the safety and privacy of the subjects and the confidentiality of the data. (3) Appropriate
safeguards are included to protect the rights and welfare of the subjects.
a. Your research therefore meets the criteria of Expedited Review and is Approved.
2. Please note that the institution is not responsible for any actions regarding this protocol
before approval. If you expand the project at a later date to use other instruments please re-apply.
Copies of your request for human subjects review, your application, and this approval, are
maintained in the Office of Sponsored Programs at the above address. Please report any changes
to this approved protocol to this office. A Continuing Review protocol will be sent to you in
the future to determine the status of the project.
Sincerely,
Phillip E. Myers, Ph.D.
Director, OSP and
Human Protections Administrator
cc: Human Subjects File HS04-004
cc: Dr. Donna Blackburn
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